Blockade IMARC

Fobi Announces the Closing of its Acquisition of PassWallet Assets from Quicket GmbH, and an Increase of 1.28m Downloads Since First Reported on Oct. 7, 2021

Retrieved on: 
Monday, November 8, 2021
Android, Museum, CAGR, TSX Venture Exchange, IOT, Growth, Calendar, Sport, Kingsley Fobi, Kroenke Sports & Entertainment, Vendor, Acquisition, Bank, Bank of Canada, Company, GLOBE, Blockade IMARC, Solution, Cryptocurrency wallet, Cryptocurrency

The mobile wallet provides a convenient, secure way to streamline operations and deliver enhanced levels of personalized engagement directly to users, and even to their mobile phones lock screen.

Key Points: 
  • The mobile wallet provides a convenient, secure way to streamline operations and deliver enhanced levels of personalized engagement directly to users, and even to their mobile phones lock screen.
  • A recent Imarc report forecasts the Mobile Wallet market will grow at a compound annual growth rate (CAGR) of 20% from 2021-2026.
  • This Press Release Is Available on the Fobi Website , as well as the FOBI Verified Forum On AGORACOM For Shareholder Discussion And Management Engagement.
  • PassWallet is thefirst appspecializing in enabling Android users to store, organize and update Wallet passes, in the most simple and intuitive way.

Diagnos A.I. retinal screening technology expands into international markets

Retrieved on: 
Thursday, August 5, 2021
Efficiency, Industry, ADK, Optometry, Multimedia, Eye, Toronto Stock Exchange, Severe cognitive impairment, Hospital, Algorithm, Chum, Artificial intelligence, Ai, Retina, Jody Vance, Capillary, Federal Commission for the Protection against Sanitary Risk, Diabetes, EC, Food and Drug Administration, Clinic, FRA, Solution, Anomaly, Population, Technology, Vein, Levon Larents, Cara, Medicine, Stroke, Partnership, Artery, Health Canada, Aneurysm, BCI, Patient safety, Adoption, Atherosclerosis, Blockade IMARC, Patient, Bleeding, AV, Risk, Adult, Iris, Disease, Drug, Medical device, Medical imaging, Telescopic sight, Cryptocurrency, Pharmaceutical industry

CARA's artificial intelligence-based image enhancement algorithms provide sharper, clearer, retinal images that can then be analyzed for anomalies.

Key Points: 
  • CARA's artificial intelligence-based image enhancement algorithms provide sharper, clearer, retinal images that can then be analyzed for anomalies.
  • "IRIS continues to be at the forefront of implementing technology driven solutions for clinical optometry and optical retail," stated said Eric Babin, President of IRIS.
  • "Artificial intelligence will raise our standard when it comes to quality of care and we are eager to collaborate with Diagnos."
  • Diagnos' technology can inform a patient that she is at risk for a heart attack or stroke.